Review Article

CDK/CCN and CDKI Alterations for Cancer Prognosis and Therapeutic Predictivity

Table 2

Cell cycle modulators and their molecular target optimal therapeutic inhibitors.

AgentTarget

StaurosporineCDK1, CDK2, CDK4
FlavopiridolCDK1, CDK2, CDK4, CCND
ButyrolactoneCDK1, CDK2
PaullonesCDK1, CDK2, CDK5
IndirubinCDK1, CDK2, CDK4, CDK5
RapamycinCCND, CCNA
OlomoucineCDK1, CDK2, CDK5
IsopentenyladenineCDK1, CDK2